Every SEC Form 3/4/5 on record for this filer (CIK 1864871) — 1 issuer, 8 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| NRXP | NRX Pharmaceuticals, Inc. | Director | 2021-06-10 → 2025-09-10 | 5 | $14,663 |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| NRXP | 2022-11-28 | Buy | 2,500 | $1.25 | $3,125 | 37,709 |
| NRXP | 2022-11-28 | Buy | 2,500 | $1.25 | $3,125 | 37,709 |
| NRXP | 2022-11-28 | Buy | 2,500 | $1.24 | $3,100 | 40,209 |
| NRXP | 2022-11-28 | Buy | 1,750 | $1.25 | $2,188 | 1,750 |
| NRXP | 2022-11-28 | Buy | 2,500 | $1.25 | $3,125 | 40,209 |
1 of 1 issuers are covered and open a security page; the rest are on file here only.